Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Clues to Cause of Stomach Cancer

By Biotechdaily staff writers
Posted on 24 Sep 2002
Researchers have found that mutations on a receptor molecule called gp130 in mice resulted in symptoms that mirrored those of gastric cancer and large bowel inflammation in humans, suggesting targets for drugs to treat these conditions. More...
The research was reported in the October 2002 issue of Nature Medicine.

The gp130 molecule is found on the surface of cells and is traditionally involved in helping to regulate the body's immune system. The molecule serves as a molecular antenna, transmitting instructions from cytokines to individual cells, telling them how to respond to their environment. The researchers were surprised when mice carrying the mutations in gp130 developed cellular changes similar to those of gastric cancer.

"Nobody suspected that interference with the messenger service engaged by gp130 could be linked with a 100% prevalence of early stages of gastric cancer in mice,” said Andy Giraud, associate professor at the University of Melbourne (Australia) and a member of the research team.

On set of mice had a single amino acid change to the gp130 molecule, which induced the changes reminiscent of early gastric cancer. A second set of mice has a small chunk chopped off the end of the molecule. This set showed reduced ability to repair damage in the colon and rectum, making them susceptible to intestinal injury resulting in large bowel inflammation.

"What has been designed as a regenerative mechanism gets out of control in the stomach with one mutation, while not being activated in the large bowel as a result of the other mutation. What we have yet to find is the cancer spreading to other organs, which is what eventually kills patients,” said Dr. Matthias Ernst, of the Ludwig Institute for Cancer Research in Melbourne, also a member of the research team.




Related Links:
University of Melbourne

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
Immunofluorescence Analyzer
IFA System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Dr. Olivia Belbin, head of the Molecular Neurodegeneration Group at IR Sant Pau and study corresponding author, with Alba Cervantes (right), first author and IR Sant Pau researcher (Photo courtesy of IR Sant Pau)

Blood Biomarker Detects Alzheimer’s Changes Decades Before Symptoms in Down Syndrome

Alzheimer’s disease can begin altering the brain long before clinical symptoms appear, creating a challenge for early-stage detection and research. People with Down syndrome face a particularly high age-related... Read more

Molecular Diagnostics

view channel
Photo courtesy of National Human Genome Research Institute

Genomic Screening Expands Detection of Treatable Conditions in Newborns

Conventional newborn screening can miss conditions that lack biochemical biomarkers or present atypically. Initial hearing screens may also fail to detect hearing loss that is later identified through... Read more

Microbiology

view channel
Image: Invasive aspergillosis (IA) is a potentially life-threatening infection caused by Aspergillus mold that primarily affects people with severely weakened immune systems. (Image Credit: Adobe Stock)

Rapid Urine Test Aids Diagnosis of Invasive Aspergillosis

Invasive aspergillosis is an uncommon mold infection in the general population but can pose serious risks for people with weakened immune defenses. Diagnosis can be difficult because existing approaches... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: NMPA approvals for Quanterix HD-X and SR-X instruments and four neurology biomarker assays expand access to ultrasensitive blood-based testing in China (Photo courtesy of Quanterix Corporation)

Regulatory Milestone Expands Access to Blood-Based Neurology Biomarker Testing in China

Quanterix Corporation (Billerica, MA, USA) and Innovita Biological Technology Co., Ltd. (Beijing, China) announced regulatory approvals that expand access to Quanterix SIMOA technology and neurology biomarker... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.